MedPath

A Novel Strabismus Screening Device Based on Virtual Reality Head-Mounted Displays with Eye Tracking System in Measuring the Angle of Deviation in Constant Concomitant Horizontal Strabismus

Not Applicable
Recruiting
Conditions
The angle of deviation in constant concomitant horizontal strabismus.
Strabismus
angle
deviation
virtual reality
eye tracking
alternate prism cover test
constant
concomitant
horizontal strabismus
Registration Number
TCTR20180422001
Lead Sponsor
THE 90 TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND ( Ratchadaphiseksomphot Endowment Fund)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1.Adult aged 18-60 years in muscle clinic, KCMH
2.Constant concomitant horizontal strabismus; defined as horizontal strabismus that angle of deviation does not change in different gaze position, and the deviation can be noticed at all time.
3.Angle of deviation equals to or more than 10 prism diopters
4.Difference of near and distance angle of deviation equals to or less than 10 prism diopters
5.Best corrected visual acuity of both eyes equal to or better than 20/30.

Exclusion Criteria

1.Range of ocular duction less than 80 prism diopters
2.Angle kappa
3.Eccentric fixation
4.Anterior segment eye abnormalities
5.Restrictive or paralytic strabismus
6.Nystagmus
7.Neurological underlying disease
8.Unable to cooperate / noncommunicative patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the agreement of a novel adapted virtual reality head-mounted displays (VR HMDs) with e after end of the intervention immediately Intra-class correlation (ICC) and Bland-Altman plot
Secondary Outcome Measures
NameTimeMethod
To determine repeatability of a novel adapted virtual reality head-mounted displays (VR HMDs) with e after end of the intervention immediately Intra-class correlation (ICC)
© Copyright 2025. All Rights Reserved by MedPath